Byers R M, Clayman G L, McGill D, Andrews T, Kare R P, Roberts D B, Goepfert H
Department of Head and Neck Surgery, Box 69, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030, USA.
Head Neck. 1999 Sep;21(6):499-505. doi: 10.1002/(sici)1097-0347(199909)21:6<499::aid-hed1>3.0.co;2-a.
Surgeons have been using selective neck dissections in the treatment of squamous carcinoma of the upper aerodigestive tract for over 20 years. To date, no data is available that can answer the question "What are the patterns of failure in the neck following a selective neck dissection and is a selective neck dissection a reliable procedure for metastatic disease?"
To answer this question, the medical records of all patients with squamous carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx treated at The University of Texas M. D. Anderson Cancer Center from January 1, 1985-December 31, 1990, with a selective neck dissection were reviewed. Five hundred seventeen neck dissections were analyzed: suprahyoid (41), supraomohyoid (284), and anterolateral (192). The end point of the study was regional failure and survival.
Regional recurrence in patients treated with a suprahyoid dissection was 43% with pathologically positive nodes. The regional recurrence in the patients treated with a supraomohyoid neck dissection was 1.9% with pathologically negative nodes, 35.7% with path N1 without postoperative radiation therapy, and 5.6% with postoperative radiation therapy. The neck staged pathologically N2B failed with and without postoperative radiation, 8.3% and 14%, respectively. Thirteen percent of the anterior/lateral neck dissections failed regionally. If multiple pathologically positive nodes (N2B) were present, the regional failure with postoperative radiation was 30% and 33.3% without postoperative radiation.
The results of this retrospective study suggest that a selective neck dissection is a satisfactory staging procedure and is a definitive operation if all the nodes are pathologically negative. However, if a node is found to be invaded with cancer, the use of postoperative radiation is advisable.
20多年来,外科医生一直采用选择性颈清扫术治疗上消化道鳞状细胞癌。迄今为止,尚无数据能够回答“选择性颈清扫术后颈部的失败模式是什么,以及选择性颈清扫术对于转移性疾病是否是一种可靠的手术?”这一问题。
为回答该问题,回顾了1985年1月1日至1990年12月31日在德克萨斯大学MD安德森癌症中心接受选择性颈清扫术治疗的所有口腔、口咽、喉和下咽鳞状细胞癌患者的病历。分析了517例颈清扫术:舌骨上(41例)、肩胛舌骨肌上(284例)和前外侧(192例)。研究的终点是区域失败和生存。
舌骨上清扫术治疗的患者中,病理阳性淋巴结患者的区域复发率为43%。肩胛舌骨肌上颈清扫术治疗的患者中,病理阴性淋巴结患者的区域复发率为1.9%,N1期且未接受术后放疗的患者为35.7%,接受术后放疗的患者为5.6%。病理分期为N2B的颈部无论有无术后放疗均失败,分别为8.3%和14%。13%的前外侧颈清扫术出现区域失败。如果存在多个病理阳性淋巴结(N2B),术后放疗的区域失败率为30%,未进行术后放疗的为33.3%。
这项回顾性研究的结果表明,选择性颈清扫术是一种令人满意的分期手术,如果所有淋巴结病理阴性则是一种确定性手术。然而,如果发现有淋巴结被癌侵犯,建议使用术后放疗。